NF-κB p105 Protein

Pathway Diagram

flowchart TD
    NFKB["NF-kappaB<br/>Transcription Factor"]
    TLR4["TLR4<br/>Toll-like Receptor 4"]
    TGM2["TGM2<br/>Transglutaminase 2"]
    BRSK2["BRSK2<br/>Kinase"]
    TMAO["TMAO<br/>Metabolite"]
    
    IKBA["IkappaBalpha<br/>Inhibitor Protein"]
    NFKBIA["NFkappaBIA<br/>Inhibitor Gene"]
    PPARG["PPARgamma<br/>Nuclear Receptor"]
    IRISIN["IRISIN<br/>Myokine"]
    Osmotin["Osmotin<br/>Plant Protein"]
    
    NEUROINFLAMMATION["Neuroinflammation<br/>Process"]
    SASP["SASP<br/>Senescence Program"]
    NLRP3["NLRP3<br/>Inflammasome"]
    IL8["IL-8<br/>Cytokine"]
    C3["C3<br/>Complement"]
    
    ALZHEIMERS["Alzheimer's Disease<br/>Pathology"]
    SQSTM1["SQSTM1/p62<br/>Autophagy Receptor"]
    
    TLR4 -->|"activates"| NFKB
    TGM2 -->|"activates"| NFKB
    BRSK2 -->|"activates"| NFKB
    TMAO -->|"activates"| NFKB
    
    IKBA -->|"inhibits"| NFKB
    NFKBIA -->|"inhibits"| NFKB
    PPARG -->|"inhibits"| NFKB
    IRISIN -->|"inhibits"| NFKB
    Osmotin -->|"inhibits"| NFKB
    
    NFKB -->|"activates"| NEUROINFLAMMATION
    NFKB -->|"regulates"| SASP
    NFKB -->|"upregulates"| NLRP3
    NFKB -->|"upregulates"| IL8
    NFKB -->|"regulates"| C3
    NFKB -->|"upregulates"| SQSTM1
    
    NFKB -->|"contributes_to"| ALZHEIMERS
    NEUROINFLAMMATION -->|"promotes"| ALZHEIMERS
    
    style NFKB fill:#006494
    style PPARG fill:#1b5e20
    style IRISIN fill:#1b5e20
    style Osmotin fill:#1b5e20
    style NEUROINFLAMMATION fill:#ef5350
    style SASP fill:#ef5350
    style ALZHEIMERS fill:#5d4400
    style IKBA fill:#4a1a6b
    style NFKBIA fill:#4a1a6b
    style NLRP3 fill:#6d3b00
    style IL8 fill:#6d3b00

Introduction

Nf Κb P105 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

NF-kappaB p105 is the precursor form encoded by NFKB1. Proteasome-dependent processing of p105 generates the p50 subunit, a core component of canonical NF-kappaB transcriptional complexes that regulate inflammatory, stress-response, and survival gene programs in the central nervous system.^{1NF-kappaB, the first quarter-century: remarkable progress and outstanding questions2012 · Genes Dev · DOI 10.1101/gad.183434.111Open reference2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference} In neurodegeneration, p105/p50 signaling is a major convergence node linking microglia, astrocytes, and vulnerable neurons to sustained cytokine signaling and synaptic dysfunction.^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference4NFkappaB-activated astroglial release of complement C3 compromises neuronal morphology and function2015 · Neuron · DOI 10.1016/j.neuron.2015.08.018Open reference}

Domain Architecture and Processing Logic

p105 contains an N-terminal Rel homology domain (RHD) responsible for DNA binding/dimerization and a C-terminal ankyrin-repeat region that has IkappaB-like inhibitory properties. This dual architecture allows p105 to function both as a precursor to p50 and as a scaffold-like inhibitor retaining Rel proteins in the cytoplasm until pathway activation cues are received.^{1NF-kappaB, the first quarter-century: remarkable progress and outstanding questions2012 · Genes Dev · DOI 10.1101/gad.183434.111Open reference5Crosstalk in NF-kappaB signaling pathways2065 · Nat Immunol · DOI 10.1038/ni.2065Open reference}

Upon receptor-driven signaling (for example through TNF, IL-1, or pattern-recognition pathways), IKK-mediated phosphorylation and ubiquitin-dependent proteolysis drive partial processing of p105 to p50 or complete degradation, thereby changing the transcriptional state of the cell.^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference5Crosstalk in NF-kappaB signaling pathways2065 · Nat Immunol · DOI 10.1038/ni.2065Open reference} Coupling to the ubiquitin-proteasome system makes this step sensitive to proteostasis stress, a recurrent feature of AD and PD brains.^{6Protein quality control by molecular chaperones in neurodegeneration2017 · Neuron · DOI 10.1016/j.neuron.2017.05.007Open reference}

NF-kappaB p105 in CNS Cell Types

In microglia, canonical NF-kappaB signaling amplifies production of IL-1beta, TNF, and chemokines that reinforce neuroinflammatory loops and can accelerate synapse loss in disease contexts.^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}0 In astrocytes, p50-containing complexes help control transition toward reactive states that alter glutamate handling, trophic support, and blood-brain barrier communication.^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}1^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}2 In neurons, activity-dependent NF-kappaB signaling has context-dependent roles: it can support survival and plasticity under physiological conditions but becomes maladaptive under chronic inflammatory or oxidative stress.^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}3^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}4

Alzheimer’s Disease Mechanistic Relevance

AD-relevant stimuli including soluble Aβ oligomers and fibrillar amyloid activate NF-kappaB signaling in glia and neurons. This increases expression of inflammatory mediators and can feed forward into APP-processing and tau-phosphorylation pathways.^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}5^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}6 Cross-talk between APP/NCT-dependent proteolytic systems and NF-kappaB-regulated transcription is an active area of study, especially for understanding stage-specific transitions from compensatory to toxic inflammation.^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}7^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}8

Beyond inflammation, NF-kappaB influences genes controlling synaptic plasticity and mitochondrial resilience. Dysregulated p105/p50 signaling may therefore contribute simultaneously to cognitive decline and neuroimmune activation in AD.^{2NF-kappaB in the nervous system2009 · Cold Spring Harb Perspect Biol · DOI 10.1101/cshperspect.a001271Open reference}9^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference}0

Parkinson’s Disease and Synucleinopathies

In PD and related synucleinopathies, alpha-synuclein species activate microglial pattern-recognition pathways that converge on IKK-NF-kappaB signaling. Elevated p50/Rel complexes are observed in affected regions, consistent with chronic innate immune activation and progressive dopaminergic stress.^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference}1^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference}2 These mechanisms intersect with mitochondrial dysfunction, lysosomal impairment, and oxidant stress, linking inflammatory transcriptional programs to neuronal vulnerability in the substantia nigra.^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference}3^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference}4

Therapeutic Implications

Direct global NF-kappaB blockade has been limited by broad immunologic and homeostatic liabilities. Current translational strategies are shifting toward cell-type-selective modulation, upstream trigger control (for example inflammasome or TLR signaling), or context-tuned pathway dampening rather than full suppression.^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference}5^{3Inflammasome signalling in brain function and neurodegenerative disease2018 · Nat Rev Neurosci · DOI 10.1038/s41583-018-0055-7Open reference}6 Mapping p105-specific processing checkpoints may provide finer control points, particularly where proteasome state or scaffold function determines inflammatory set point.

Open Questions

1. Which p105 processing states in human brain best predict transition from adaptive to maladaptive neuroinflammation?

2. Can microglia- or astrocyte-selective NF-kappaB modulation preserve host defense while reducing neurotoxicity?

3. How do p105-dependent transcriptional programs interact with amyloid and synuclein proteostasis pathways over disease stage?

See Also

• NFKB1 Gene

• NCT (Nicastrin) Gene

• Microglia in Chronic Neuroinflammation

• Reactive Astrocytes (A2 Phenotype)

• Parkinson’s Disease

• Alzheimer’s Disease

Background

The study of Nf Κb P105 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• PubMed - Biomedical literature

• Alzheimer’s Disease Neuroimaging Initiative - Research data

• Allen Brain Atlas - Brain gene expression data